Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

SELL
$7.95 - $11.68 $37,627 - $55,281
-4,733 Reduced 90.45%
500 $5,000
Q3 2022

Nov 04, 2022

SELL
$4.41 - $8.38 $13,723 - $26,078
-3,112 Reduced 37.29%
5,233 $29,000
Q2 2022

Aug 03, 2022

BUY
$3.6 - $11.2 $24,397 - $75,902
6,777 Added 432.21%
8,345 $36,000
Q1 2022

May 02, 2022

BUY
$8.58 - $17.65 $13,453 - $27,675
1,568 New
1,568 $18,000

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.